497 related articles for article (PubMed ID: 37834203)
1. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
2. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
3. Dietary ellagic acid therapy for CNS autoimmunity: Targeting on Alloprevotella rava and propionate metabolism.
Han B; Shi L; Bao MY; Yu FL; Zhang Y; Lu XY; Wang Y; Li DX; Lin JC; Jia W; Li X; Zhang Y
Microbiome; 2024 Jun; 12(1):114. PubMed ID: 38915127
[TBL] [Abstract][Full Text] [Related]
4. Role of Gut Microbiota in Multiple Sclerosis and Potential Therapeutic Implications.
Wang X; Liang Z; Wang S; Ma D; Zhu M; Feng J
Curr Neuropharmacol; 2022; 20(7):1413-1426. PubMed ID: 34191698
[TBL] [Abstract][Full Text] [Related]
5. Feeding the gut microbiome: impact on multiple sclerosis.
Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M
Front Immunol; 2023; 14():1176016. PubMed ID: 37304278
[TBL] [Abstract][Full Text] [Related]
6. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.
Zhang ML; Li WX; Wang XY; Wu YL; Chen XF; Zhang H; Yang LQ; Wu CZ; Zhang SQ; Chen YL; Feng KR; Wang B; Niu L; Kong DX; Tang JF
Front Cell Infect Microbiol; 2022; 12():1095053. PubMed ID: 36710971
[TBL] [Abstract][Full Text] [Related]
7. Obesity induced gut dysbiosis contributes to disease severity in an animal model of multiple sclerosis.
Shahi SK; Ghimire S; Lehman P; Mangalam AK
Front Immunol; 2022; 13():966417. PubMed ID: 36164343
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
[TBL] [Abstract][Full Text] [Related]
9. GPR43 stimulation on TCRαβ
Prado C; Espinoza A; Martínez-Hernández JE; Petrosino J; Riquelme E; Martin AJM; Pacheco R
J Neuroinflammation; 2023 Jun; 20(1):135. PubMed ID: 37264394
[TBL] [Abstract][Full Text] [Related]
10. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
[TBL] [Abstract][Full Text] [Related]
11. Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Fan Y; Zhang J
Front Microbiol; 2019; 10():740. PubMed ID: 31040833
[TBL] [Abstract][Full Text] [Related]
12. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
Kumar N; Sahoo NK; Mehan S; Verma B
Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
[TBL] [Abstract][Full Text] [Related]
13. Impacts of microbiome metabolites on immune regulation and autoimmunity.
Haase S; Haghikia A; Wilck N; Müller DN; Linker RA
Immunology; 2018 Jun; 154(2):230-238. PubMed ID: 29637999
[TBL] [Abstract][Full Text] [Related]
14. Short-chain fatty acids and gut microbiota in multiple sclerosis.
Melbye P; Olsson A; Hansen TH; Søndergaard HB; Bang Oturai A
Acta Neurol Scand; 2019 Mar; 139(3):208-219. PubMed ID: 30427062
[TBL] [Abstract][Full Text] [Related]
15. Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
Adamczyk-Sowa M; Medrek A; Madej P; Michlicka W; Dobrakowski P
J Immunol Res; 2017; 2017():7904821. PubMed ID: 28316999
[No Abstract] [Full Text] [Related]
16. Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.
Yadav SK; Boppana S; Ito N; Mindur JE; Mathay MT; Patel A; Dhib-Jalbut S; Ito K
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9318-E9327. PubMed ID: 29078267
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.
Chu F; Shi M; Lang Y; Shen D; Jin T; Zhu J; Cui L
Mediators Inflamm; 2018; 2018():8168717. PubMed ID: 29805314
[TBL] [Abstract][Full Text] [Related]
18. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
Brown J; Quattrochi B; Everett C; Hong BY; Cervantes J
Mult Scler; 2021 May; 27(6):807-811. PubMed ID: 32507072
[TBL] [Abstract][Full Text] [Related]
19. The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
Freedman SN; Shahi SK; Mangalam AK
Neurotherapeutics; 2018 Jan; 15(1):109-125. PubMed ID: 29204955
[TBL] [Abstract][Full Text] [Related]
20. Impact of Disease-Modifying Therapies on Gut-Brain Axis in Multiple Sclerosis.
Del Negro I; Pez S; Versace S; Marziali A; Gigli GL; Tereshko Y; Valente M
Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38276041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]